Escenta Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Nagpur, Maharashtra, India, established in 2019.
2019 Nagpur, Maharashtra, India Struck Off
Last Updated:
Access Report
About Escenta Pharma Private Limited

Escenta Pharma Private Limited, a struck off private limited company, was established on 16 November 2019 in Nagpur, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24290MH2019PTC333083. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mangesh Eknath Bhad (Director), Ajit Parasmal Soni (Director). Its latest AGM occurred on 21 June 2021, with the balance sheet filed on 31 March 2021. It is based at 801 Jai Kalpana Apartments,35 Farmland, Ramdaspeth, Nagpur, Maharashtra, 440010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2019PTC333083

  • Registration Number

    333083

  • Incorporation Date

    16 November 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 3 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets -3.56%
Company report

Escenta Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Escenta Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Escenta Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Mangesh Eknath Bhad Director 16 Nov 2019 Current
Ajit Parasmal Soni Director 16 Nov 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Escenta Pharma.

Escenta Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Escenta Pharma revenue growth over time
Escenta Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -3.56%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Escenta Pharma?

Unlock access to Escenta Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Escenta Pharma?

Unlock and access historical data on people associated with Escenta Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Escenta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Escenta Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Escenta Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Escenta Pharma Private Limited last Annual general meeting of members was held on 21 Jun 2021 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Escenta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Mangesh Eknath Bhad was appointed as a Director was appointed as a Director on 16 Nov 2019 & has been associated with this company since 6 years 3 months . was completed.

  • Director Appointment

    The activity Ajit Parasmal Soni was appointed as a Director was appointed as a Director on 16 Nov 2019 & has been associated with this company since 6 years 3 months . was completed.

  • Company Incorporation

    Escenta Pharma Private Limited was registered on 16 Nov 2019 with Roc Mumbai & aged 6 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Escenta Pharma Private Limited?

The CIN of Escenta Pharma Private Limited is U24290MH2019PTC333083.

Where is Escenta Pharma Private Limited headquartered?

Escenta Pharma Private Limited is headquartered at 801 Jai Kalpana Apartments,35 Farmland, Ramdaspeth, Nagpur, Maharashtra, 440010.

When was Escenta Pharma Private Limited incorporated?

Escenta Pharma Private Limited was incorporated on 16 November 2019.

Who are the current directors of Escenta Pharma Private Limited?

The current directors of Escenta Pharma Private Limited are

What is the primary industry of Escenta Pharma Private Limited?

The primary industry of Escenta Pharma Private Limited is Chemicals.

Is Escenta Pharma Private Limited a listed company?

Escenta Pharma Private Limited is unlisted.

What is the capital structure of Escenta Pharma Private Limited?

The authorized capital of Escenta Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available